Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Equity Ratio (2023 - 2025)

Connect Biopharma Holdings' Equity Ratio history spans 2 years, with the latest figure at 0.82 for Q3 2025.

  • For Q3 2025, Equity Ratio changed N/A year-over-year to 0.82; the TTM value through Sep 2025 reached 0.82, changed N/A, while the annual FY2024 figure was 0.91, N/A changed from the prior year.
  • Equity Ratio for Q3 2025 was 0.82 at Connect Biopharma Holdings, down from 0.86 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.91 in Q4 2024 and bottomed at 0.82 in Q3 2025.